MedTrace Logo

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

NCT00470327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-05-14

No results posted yet for this study

Summary

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Conditions

Sponsors & Collaborators

  • Idiopathic Pulmonary Fibrosis Clinical Research Network

    collaborator NETWORK

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Mary E Strek, MD · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470327 on ClinicalTrials.gov